AC Immune (ACIU) Operating Income (2015 - 2026)
AC Immune's (ACIU) quarterly Operating Income came in at -$18.9 million in Q1 2026, up 12.35% year-on-year from -$16.8 million in Q1 2025, and down 4.86% on a QoQ basis from -$18.0 million in Q4 2025.
AC Immune (ACIU) Operating Income (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has 12 years of Operating Income data on file, last reported at -$18.9 million in Q1 2026.
- On a quarterly basis, Operating Income rose 12.35% year-over-year to -$18.9 million in Q1 2026; TTM through Mar 2026 was -$80.5 million, a 39.83% decrease from a year earlier, with the FY2025 full-year figure at -$83.6 million, down 39.83% from the prior year.
- Operating Income for Q1 2026 stood at -$18.9 million, down from -$18.0 million in the prior quarter.
- Over the last five years, Operating Income for ACIU reached as high as $8.4 million in Q3 2024 and fell as low as -$23.4 million in Q2 2025.
- Historically, Operating Income has averaged -$17.3 million across 5 years, with a median of -$19.4 million in 2022.
- On a YoY basis, Operating Income climbed as much as 147.92% in 2024 and fell as far as 432.39% in 2024.
- Year by year, Operating Income stood at -$19.4 million in 2022, then surged by 79.43% to -$4.0 million in 2023, then tumbled by 432.39% to -$21.3 million in 2024, then increased by 15.26% to -$18.0 million in 2025, then fell by 4.86% to -$18.9 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were -$18.9 million in Q1 2026, -$18.0 million in Q4 2025, and -$20.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | -18.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.88 Mn |
| Dec 31, 2025 | -18.01 Mn |
| Sep 30, 2025 | -20.21 Mn |
| Jun 30, 2025 | -23.42 Mn |
| Mar 31, 2025 | -21.54 Mn |
| Dec 31, 2024 | -21.25 Mn |
| Sep 30, 2024 | 8.39 Mn |
| Jun 30, 2024 | -23.18 Mn |
| Mar 31, 2024 | -22.99 Mn |
| Dec 31, 2023 | -3.99 Mn |
| Sep 30, 2023 | -17.51 Mn |
| Jun 30, 2023 | -18.96 Mn |
| Mar 31, 2023 | -19.00 Mn |
| Dec 31, 2022 | -19.41 Mn |
| Sep 30, 2022 | -13.94 Mn |
| Jun 30, 2022 | -20.62 Mn |
| Mar 31, 2022 | -20.39 Mn |
| Dec 31, 2021 | -24.71 Mn |
| Sep 30, 2021 | -22.09 Mn |
| Jun 30, 2021 | -20.50 Mn |